Skip to main content
SpringerLink
Log in

E Test Susceptibility Testing of Nosocomial Clostridium difficile Isolates Against Metronidazole, Vancomycin, Fusidic Acid and the Novel Agents Moxifloxacin, Gatifloxacin, and Linezolid

  • Brief Report
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Department of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, Hospital Road, Concord, 2139 Sydney, New South Wales, Australia

    M. Leroi, S. Siarakas & T. Gottlieb

Authors
  1. M. Leroi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Siarakas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Gottlieb
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leroi, M., Siarakas, S. & Gottlieb, T. E Test Susceptibility Testing of Nosocomial Clostridium difficile Isolates Against Metronidazole, Vancomycin, Fusidic Acid and the Novel Agents Moxifloxacin, Gatifloxacin, and Linezolid. Eur J Clin Microbiol Infect Dis 21, 72–74 (2002). https://doi.org/10.1007/s10096-001-0658-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-001-0658-0

Search

Navigation